Human Biolife India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.00 M
as on 10-12-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 10.96%
(FY 2023)
- Profit 27.49%
(FY 2023)
- Ebitda 53.96%
(FY 2023)
- Net Worth 40.10%
(FY 2023)
- Total Assets 16.99%
(FY 2023)
About Human Biolife India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Jaiswal and Kali Jaiswal serve as directors at the Company.
- CIN/LLPIN
U24233UP2014PTC067770
- Company No.
067770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2014
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Human Biolife India Private Limited offer?
Human Biolife India Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Dietary Supplements, Common Disease Medicines, Antihistamines, Antifungal Injection, Tablet & Syrup, Nasal Drops, Sexual Wellness Products.
Who are the key members and board of directors at Human Biolife India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Jaiswal  | Managing Director | 23-Dec-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kali Jaiswal | Director | 23-Dec-2014 | Current |
Financial Performance of Human Biolife India.
Human Biolife India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.96% increase. The company also saw a substantial improvement in profitability, with a 27.49% increase in profit. The company's net worth Soared by an impressive increase of 40.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Human Biolife India?
Unlock access to Human Biolife India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nexwin Pharma Private LimitedActive 4 years 3 monthsJyoti Jaiswal and Kali Jaiswal are mutual person
- Sparkbless Pharma Private LimitedActive 3 years 2 months
Jyoti Jaiswal and Kali Jaiswal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Human Biolife India?
Unlock and access historical data on people associated with Human Biolife India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Human Biolife India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Human Biolife India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
